Literature DB >> 34914055

Development of Human Recombinant Leptospirosis Vaccines.

Natasha Rodrigues de Oliveira1, Thaís Larré Oliveira1, Sérgio Jorge2, Odir Antônio Dellagostin3.   

Abstract

Leptospirosis is a bacterial zoonotic disease with significant impact on health all over the world. Currently, bacterins are the only vaccines available for prevention of this disease, despite several drawbacks. In an effort to develop a more effective vaccine against leptospirosis, reverse and structural vaccinology have been applied to design recombinant constructions composed of leptospiral surface-exposed antigens. Herein, we describe a protocol for design and development of Leptospirosis recombinant vaccines using immunoinformatic approaches.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Experimental infection; Leptospira; Recombinant protein; Structural modeling

Mesh:

Substances:

Year:  2022        PMID: 34914055     DOI: 10.1007/978-1-0716-1884-4_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  25 in total

1.  BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative bacteria.

Authors:  Frode S Berven; Kristian Flikka; Harald B Jensen; Ingvar Eidhammer
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

Review 2.  Whole-cell inactivated leptospirosis vaccine: future prospects.

Authors:  Ramesh Verma; Pardeep Khanna; Suraj Chawla
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

Review 3.  Human leptospirosis vaccines in China.

Authors:  Yinghua Xu; Qiang Ye
Journal:  Hum Vaccin Immunother       Date:  2017-12-19       Impact factor: 3.452

4.  LemA and Erp Y-like recombinant proteins from Leptospira interrogans protect hamsters from challenge using AddaVax™ as adjuvant.

Authors:  Thaís Larré Oliveira; Rodrigo Andrade Schuch; Guilherme Roig Inda; Bárbara Couto Roloff; Amilton Clair Pinto Seixas Neto; Marta Amaral; Odir Antonio Dellagostin; Daiane Drawanz Hartwig
Journal:  Vaccine       Date:  2018-04-03       Impact factor: 3.641

5.  Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.

Authors:  D Monaris; M E Sbrogio-Almeida; C C Dib; T A Canhamero; G O Souza; S A Vasconcellos; L C S Ferreira; P A E Abreu
Journal:  Clin Vaccine Immunol       Date:  2015-06-24

6.  Recombinant BCG strains expressing chimeric proteins derived from Leptospira protect hamsters against leptospirosis.

Authors:  Thaís Larré Oliveira; Caroline Rizzi; Carlos Eduardo Pouey da Cunha; Jessica Dorneles; Amilton Clair Pinto Seixas Neto; Marta Gonçalves Amaral; Daiane Drawanz Hartwig; Odir Antônio Dellagostin
Journal:  Vaccine       Date:  2019-01-07       Impact factor: 3.641

7.  [Efficacy and safety of a vaccine against human leptospirosis in Cuba].

Authors:  Raydel Martínez; Alberto Pérez; María del C Quiñones; Raúl Cruz; Angel Alvarez; Marlén Armesto; Carmen Fernández; Jorge Menéndez; Islay Rodríguez; Morelia Baró; Manuel Díaz; José Rodríguez; Gustavo Sierra; Ana Margarita Obregón; María Eugenia Toledo; Norma Fernández
Journal:  Rev Panam Salud Publica       Date:  2004-04

Review 8.  Recent findings related to immune responses against leptospirosis and novel strategies to prevent infection.

Authors:  Frédérique Vernel-Pauillac; Catherine Werts
Journal:  Microbes Infect       Date:  2018-02-13       Impact factor: 2.700

9.  Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology.

Authors:  André Alex Grassmann; Frederico Schmitt Kremer; Júlia Cougo Dos Santos; Jéssica Dias Souza; Luciano da Silva Pinto; Alan John Alexander McBride
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

10.  A Novel Pan-Genome Reverse Vaccinology Approach Employing a Negative-Selection Strategy for Screening Surface-Exposed Antigens against leptospirosis.

Authors:  LingBing Zeng; Dongliang Wang; NiYa Hu; Qing Zhu; Kaishen Chen; Ke Dong; Yan Zhang; YuFeng Yao; XiaoKui Guo; Yung-Fu Chang; YongZhang Zhu
Journal:  Front Microbiol       Date:  2017-03-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.